Sensorion Stock

Sensorion Equity 2025

Sensorion Equity

72.14 M EUR

Ticker

ALSEN.PA

ISIN

FR0012596468

WKN

A14SVV

In 2025, Sensorion's equity was 72.14 M EUR, a 116.79% increase from the 33.28 M EUR equity in the previous year.

Sensorion Aktienanalyse

What does Sensorion do?

The company Sensorion SA is a French biotechnology company that specializes in developing innovative therapies for hearing and balance disorders. It was founded in 2009 and is headquartered in Montpellier. Sensorion SA's business model is based on researching and developing new drugs that can be used to treat inner ear diseases. These diseases often have severe effects on the quality of life and social interaction of those affected and represent a significant unmet medical need. Sensorion SA aims to develop innovative and effective therapies to address this need. The company specializes in two main areas: hearing disorders and balance disorders. In the field of hearing disorders, Sensorion SA focuses on developing drugs to treat sensorineural hearing loss. These disorders can be caused by various factors such as aging, noise exposure, or genetic predisposition and affect the inner ear. Sensorion SA has a promising pipeline of drugs in clinical development based on different mechanisms of action. These drugs aim to protect the inner ear and restore hearing function. In the field of balance disorders, Sensorion SA focuses on developing new drugs to treat dizziness and vestibular disorders. These disorders can be caused by factors such as aging, medications, or neurological diseases and affect the balance system in the inner ear. Sensorion SA also has a promising pipeline of drugs in clinical development in this area. Sensorion SA's products are not yet available on the market as they are still in development and undergoing clinical trials. However, the company works closely with academic and industry partners to test and validate its drugs. The development of new drugs is a lengthy and costly process that can take many years. However, Sensorion SA is confident that its therapies have the potential to improve the lives of many people. Overall, Sensorion SA has a promising business model based on the development of innovative therapies for hearing and balance disorders. The company has a promising pipeline of drugs in clinical development and works closely with partners to test and validate its products. If successful, their drugs could have a significant impact on the lives of people suffering from these diseases. Sensorion ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Sensorion's Equity

Sensorion's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sensorion's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sensorion's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sensorion's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sensorion’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sensorion stock

What is the equity of Sensorion this year?

Sensorion has equity of 72.14 M EUR this year.

What was the equity of Sensorion compared to the previous year?

The equity of Sensorion has increased/decreased by 116.79% increased compared to the previous year.

What impact does a high equity have on investors of Sensorion?

A high equity is advantageous for investors of Sensorion as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Sensorion?

A low equity can be a risk for investors of Sensorion, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Sensorion affect the company?

An increase in equity of Sensorion can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Sensorion affect the company?

A reduction in equity of Sensorion can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Sensorion?

Some factors that can affect the equity of Sensorion include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Sensorion so important for investors?

The equity of Sensorion is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Sensorion take to change the equity?

To change equity, Sensorion can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Sensorion pay?

Over the past 12 months, Sensorion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sensorion is expected to pay a dividend of 0 EUR.

What is the dividend yield of Sensorion?

The current dividend yield of Sensorion is .

When does Sensorion pay dividends?

Sensorion pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sensorion?

Sensorion paid dividends every year for the past 0 years.

What is the dividend of Sensorion?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sensorion located?

Sensorion is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sensorion kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sensorion from 10/4/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/4/2025.

When did Sensorion pay the last dividend?

The last dividend was paid out on 10/4/2025.

What was the dividend of Sensorion in the year 2024?

In the year 2024, Sensorion distributed 0 EUR as dividends.

In which currency does Sensorion pay out the dividend?

The dividends of Sensorion are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sensorion

Our stock analysis for Sensorion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sensorion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.